Zobrazeno 11 - 20
of 50
pro vyhledávání: '"Francesco Pisano"'
Autor:
Lluis Asmarats, Josep Rodés-Cabau, Gilles O'Hara, Robert Sabiniewicz, Mike Foresti, Adolphe Kasongo, Serban Puricel, Jean-Bernard Masson, Paolo Pagnotta, Diego Maffeo, Giuseppe Tarantini, Stéphane Cook, Francesco Pisano, Ignacio Cruz-González, Julio Carballo, Reda Ibrahim, Adam Sukiennik, Carmelo Grasso, Jose Carlos Moreno-Samos, Mauro Chiarito, Gaetano Senatore, Nathan Messas
Publikováno v:
JACC: Cardiovascular Interventions. 11:1932-1941
Objectives This study sought to evaluate the feasibility, safety, and efficacy of the Ultraseal device for left atrial appendage closure (LAAC) (Cardia, Eagan, Minnesota) in patients with nonvalvular atrial fibrillation at high bleeding risk. Backgro
Publikováno v:
European Heart Journal: Case Reports
Background Late-onset complications of left atrial appendage occlusion (LAAO) device procedure are anecdotal and there are no such complications reported in literature using Cardia Ultraseal (Cardia, Inc., Eagan, MN, USA). Case summary We report the
Autor:
Gioel Gabrio Secco, Francesco Bedogni, Giuseppe Musumeci, Giovanni Caramanno, Stefano Galli, Marco Contarini, Piero Montorsi, Francesco Pisano, Ciro Mauro, Ferdinando Varbella, Altin Palloshi, Gianpiero D'Amico, Luca Testa, Giovanni Esposito, Giuseppe Tarantini
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 34
Bioresorbable scaffolds have emerged as a potential breakthrough for the treatment of coronary artery lesions. The need for drug release and plaque scaffolding is temporary, and leaving a permanent stent once the process of plaque recoil and vessel h
Frutto di un lavoro collettivo, questa antologia di traduzioni offre dei punti di fuga a chi studia epistemologia in Italia. Punti di fuga: ossia vie d'uscita dai programmi culturali che ancora vincolano il dibattito epistemologico italiano e, insiem
Autor:
Massimo, Manes, Elisabetta, Radin, Valentina, Pellù, Emanuele, Parodi, Donatella, Caputo, Danila, Gabrielli, Andrea, Molino, Giuseppe, Paternoster, Elisa, Pelloni, Francesco, Pisano
Publikováno v:
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia. 37(1)
Atrial fibrillation is the most common cardiac disorder among chronic nephropathic patients. Possible therapeutic approaches include the use of anticoagulants, which are able to reduce the risk of thromboembolism but lead to an increasing bleeding ri
Autor:
Elton Pllaha, Marco Rossi, Paolo Pagnotta, Riccardo Mantovani, Dennis Zavalloni Parenti, Giulio G. Stefanini, Bernhard Reimers, Francesco Pisano, Mauro Chiarito
Publikováno v:
Journal of Interventional Cardiology. 31:932-938
Aims Left atrial appendage (LAA) closure is considered an effective option in patients with non-valvular atrial fibrillation (NVAF) and contraindications to long-term oral anticoagulant (OAC) therapy. However, there are some concerns about safety of
Autor:
Paola Tellaroli, Donatella Corrado, Francesco Pisano, Attilio Varricchio, Zoran Olivari, Giampaolo Pasquetto, Luciano Moretti, Gabriele Gabrielli, Leonardo Misuraca, Alessandro Durante, Marco Mojoli, Bruno Loi, Bernardo Cortese, Chiara Rovera, Valerio Lucci, Umberto Canosi, Giuseppe Steffenino, Massimo Fineschi, Paolo Calabrò, Giulia Masiero, Alfonso Ielasi, Luigi Piatti, Pietro Mazzarotto, Annamaria Nicolino, Roberto Gistri, Sebastian Coscarelli, Gabriele Tumminello, Giuseppe Tarantini, Alessandro Colombo, Davide Piraino
Publikováno v:
Catheterization and Cardiovascular Interventions. 91:E1-E16
Objectives To compare clinical outcomes of patients treated with overlapping versus non-overlapping Absorb BVS. Background: Limited data are available on the clinical impact of stent overlap with the Absorb BVS bioresorbable stent. Methods: We compar
Autor:
Kwok Fai Leung, Pasi P. Karjalainen, Magdalena Lanocha, José Ramón Rumoroso, Francesco Pisano, Stephan Richter, András Komócsi, Luis Antonio Iñigo Garcia, Adrian Wlodarczak
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 20(12)
Background The Magmaris bioresorbable magnesium scaffold was successfully tested in in-vitro and in clinical premarket studies. Subsequently the Magmaris postmarket program aimed to review intraprocedural data of at least 2000 patients to assess user
Autor:
Francesco Pisano, Bernardo Cortese, Elisabetta Moscarella, Alessandro Colombo, Pedro Silva Orrego, Gabriele Tumminello, Maurizio Tespili, Paolo Calabrò, Rai registry investigators, Bruno Loi, Giampaolo Pasquetto, Attilio Varricchio, Alessandro Durante, Pietro Mazzarotto, Giuseppe Tarantini, Donatella Corrado, Alfonso Ielasi, Luciano Moretti, Giuseppe Steffenino
Objectives: To report 1-year clinical outcomes of bioresorbable vascular scaffold (BVS) in acute coronary syndromes (ACS) population. Background: BVS use has rapidly extended to high-risk patients as those presenting with ACS. To date limited data ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f117dc9b62750b636103acad6d98ae
http://hdl.handle.net/11591/398652
http://hdl.handle.net/11591/398652